The FDA has approved Gilead's Epclusa (sofosbuvir+velpatasvir) for hepatitis C, the first interferon-free combination treatment for all six major forms of the virus. The drug represented the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback